# Biohaven Pharmaceutical funding: rounds and investors > Biohaven Pharmaceutical has raised $280M across 2 rounds since 2016. Investors include Venrock, RA Capital Management and Connecticut Innovations. Source: https://millionrounds.com/company/biohaven-pharmaceutical (Millionrounds; every figure on the page links to its filing or article) United States · [Funded startup](https://millionrounds.com/companies) # Who invested in *Biohaven Pharmaceutical* 2 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it. Biotech Healthcare Raised 12 months ago Funding summary Updated 26 Oct 2026 **$280M** raised across 2 rounds since 2016, from 2 sources **$80M** Round **$200M** Round - **Latest round:** Round, $200M Nov 2025 - **Step-up i:** 2.5× - **Investors:** 4 See who backed them ## The funding story Each circle is a round, placed by date and sized by amount. The line above is the running total. 2018 2020 2022 2024 **$80M** Round **$200M** Round - **First round:** Round, $80M - **Biggest round:** $200M - **Between rounds:** 9 years ## The rounds - **Nov 2025** Round **$200M** *3 new* *1 returning* [Venrock](https://millionrounds.com/fund/venrock) [RA Capital Management](https://millionrounds.com/fund/ra-capital-management) [Connecticut Innovations](https://millionrounds.com/fund/connecticut-innovations) [Vivo Capital](https://millionrounds.com/fund/vivo-capital) Source recorded - **Nov 2016** Round **$80M** *1 new* [Venrock](https://millionrounds.com/fund/venrock) Reported by FinSMEs SEC filing: $40M sold, first sale Oct 2016 ## Founders and team From Biohaven Pharmaceutical's own website: 73 on the team. - **Beth Morris** Vice President, Clinical Operations - **Caroline Dircks Ph.D.** Senior Vice President, Corporate & Portfolio Operations - **Francine Healy** Vice President, Global Regulatory Documentation - **Javier Gonzalez** Vice President, CMC Technical Operations - **Jim Mather** Vice President, Clinical Operations - **Kimberly Gentile** Senior Vice President, Clinical Operations - **Lopa Bakrania** Vice President, CMC‑Regulatory Affairs - **Mary Sullivan** Vice President, Regulatory Affairs - **Matthew DeLawder** Vice President, Accounting Operations - **Michele Potashman** Vice President, Clinical Outcomes Assessments & Health Economics - **Stephanie Pfister** Vice President, Clinical Operations - **John McGill** Chief Technology Officer - **Matthew Buten** Chief Financial Officer - **Alex Greif** Senior Director, Lab Operations & Facilities - **Alexandra Peck** Lab Operations Specialist - **Ana Estrella** Senior Research Scientist - **Andrea Mondello** Senior Director, Clinical Quality Compliance - **Anita Elgin** Director, Clinical Data Management & Clinical Operations And 55 more on the team. ## Who was in which round The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led. **Round** 2016 **Round** 2025 [Venrock](https://millionrounds.com/fund/venrock) [RA Capital Management](https://millionrounds.com/fund/ra-capital-management) [Connecticut Innovations](https://millionrounds.com/fund/connecticut-innovations) [Vivo Capital](https://millionrounds.com/fund/vivo-capital) ## Everyone who backed them [Venrock](https://millionrounds.com/fund/venrock) VC firm **2** rounds [RA Capital Management](https://millionrounds.com/fund/ra-capital-management) Private equity **1** round [Connecticut Innovations](https://millionrounds.com/fund/connecticut-innovations) Government **1** round [Vivo Capital](https://millionrounds.com/fund/vivo-capital) Private equity **1** round Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=biohaven-pharmaceutical). ## Also claim to have backed them These 2 firms list Biohaven Pharmaceutical as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above. [Aisling Capital](https://millionrounds.com/fund/aisling-capital) Private equity Per its own site [J.W. CHILDS ASSOCIATES, L.P.](https://millionrounds.com/fund/j-w-childs-associates-l-p) VC firm Per its own site ## Quick answers about Biohaven Pharmaceutical ### Who invested in Biohaven Pharmaceutical? Biohaven Pharmaceutical's investors include Venrock, RA Capital Management, Connecticut Innovations and Vivo Capital. ### How much has Biohaven Pharmaceutical raised? Biohaven Pharmaceutical has raised $280M across 2 rounds since 2016. ### When did Biohaven Pharmaceutical last raise? Biohaven Pharmaceutical's most recent round was an Undisclosed round of $200M in Nov 2025. ### What was Biohaven Pharmaceutical's biggest round? Its most recent round, $200M in Nov 2025, is also its largest on record. ### Who backed Biohaven Pharmaceutical first? Biohaven Pharmaceutical's first round on record, in Nov 2016, was backed by Venrock. ### What stage is Biohaven Pharmaceutical at? Biohaven Pharmaceutical's latest named round is an Undisclosed round, in Nov 2025. ### Where is Biohaven Pharmaceutical based? Biohaven Pharmaceutical is based in the United States. ## Companies like Biohaven Pharmaceutical In the same sector, and raised in the last eighteen months. [**Star Therapeutics** $325M · Oct 2026](https://millionrounds.com/company/star-therapeutics)[**Promaxo** $106M · Oct 2026](https://millionrounds.com/company/promaxo)[**Prolific Machines** $105M · Oct 2026](https://millionrounds.com/company/prolific-machines)[**AI** $18M · Oct 2026](https://millionrounds.com/company/ai)[**Baba** $40M · Oct 2026](https://millionrounds.com/company/baba)[**IMIO** $19M · Oct 2026](https://millionrounds.com/company/imio) ## Find investors like these Search every investor by what they have actually funded, then narrow to your stage and market. Free. Open the investor searchOr these rounds in the app